Aerobic exercise training in healthy postmenopausal women: Effects of hormone therapy

Menopause

Volumn 16, Issue 4, 2009, Pages 770-776

  O'Donnell, Emma ^a   Kirwan, Lori D ^a   Goodman, Jack M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Blood flow; Cardiac output; Cardiovascular; Estrogen; Stroke volume

Indexed keywords

ESTRADIOL; OXYGEN; PLACEBO; PROGESTERONE;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY HEIGHT; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYCLING; ENDURANCE; FEMALE; GASTROCNEMIUS MUSCLE; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HORMONAL THERAPY; HUMAN; HUMAN EXPERIMENT; LEG BLOOD FLOW; LUNG VENTILATION; MENOPAUSAL SYNDROME; NORMAL HUMAN; OUTCOMES RESEARCH; OXYGEN CONSUMPTION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VASCULAR RESISTANCE; WALKING;

CARDIAC OUTPUT; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; HEART RATE; HUMANS; MIDDLE AGED; OXYGEN CONSUMPTION; PLACEBOS; POSTMENOPAUSE; PROGESTERONE; STROKE VOLUME; TESTOSTERONE; VASCULAR RESISTANCE; WALKING;

EID: 68449095058     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318198cddb     Document Type: Article

References (47)

1. Lee IM, Rexrode KM, Cook NR, Manson JE, Billing JE. Physical activity and coronary heart disease in women: is "no pain, no gain" passe? JAMA 2001;285:1447-1454.
2. Manson JE, Greenland P, LaCroix AZ, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002;347:716-725.
3. Marcus R. Post-menopausal osteoporosis. Best Pract Res Clin Obstet Gynaecol 2002;16:309-327.
4. Watts NB. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results. J Reprod Med 2002;47:82-92.
5. Barnett F, Spinks WL. Exercise self-efficacy of postmenopausal women resident in the tropics. Maturitas 2007;58:1-6.
6. Marti B. Health effects of recreational running in women. Some epidemiological and preventive aspects. Sports Med 1991;11:20-51.
7. Moreau KL, Donate AJ, Seals DR, DeSouza CA, Tanaka H. Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women. Cardiovasc Res 2003;57:861-868.
8. Sugawara J, Otsuki T, Tanabe T, Hayashi K, Maeda S, Matsuda M. Physical activity duration, intensity, and arterial stiffening in postmenopausal women. Am J Hypertens 2006;19:1032-1036.
9. Tanaka H, DeSouza CA, Seals DR. Arterial stiffness and hormone replacement use in healthy postmenopausal women. J Gerontol A Biol Sci Med Sci 1998;53:M344-M346.
10. Hagmar M, Eriksson MJ, Lindholm C, Schenck-Gustafsson K, Hirschberg AL. Endothelial function in post-menopausal former elite athletes. Clin J Sport Med 2006;16:247-252.
11. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-941.
12. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
13. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
14. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
15. Hodis HN, Mack WJ. Postmenopausal hormone therapy in clinical perspective. Menopause 2007;14:944-957.
16. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583-1587.
17. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477.
18. Harman SM, Brinton EA, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005;8:3-12.
19. Hodis HN. ELITE Trial: Early Versus Late Intervention With Estradiol. Available at: www.clinicaltrials.gov/show/NCT00114517. Accessed October 1, 2008.
20. Naftolin F, Schneider HP, Sturdee DW, et al. Guidelines for hormone treatment of women in the menopausal transition and beyond. Climacteric 2004;7:333-337.
21. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53.
22. Green JS, Stanforth PR, Gagnon J, et al. Menopause, estrogen, and training effects on exercise hemodynamics: the HERITAGE study. Med Sci Sports Exerc 2002;34:74-82.
23. Kirwan LD, Mertens DJ, Kavanagh T, Thomas SG, Goodman JM. Exercise training in women with heart disease: influence of hormone replacement therapy. Med Sci Sports Exerc 2003;35:185-192.
24. Kirwan LD, MacLusky NJ, Shapiro HM, Abramson BL, Thomas SG, Goodman JM. Acute and chronic effects of hormone replacement therapy on the cardiovascular system in healthy postmenopausal women. J Clin Endocrinol Metab 2004;89:1618-1629.
25. Durnin JV, Rahaman MM. The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr 1967;21:681-689.
26. Wheeler MJ. The determination of bio-available testosterone. Ann Clin Biochem 1995;32:345-357.
27. Gordon NF, Scott CB. Exercise intensity prescription in cardiovascular disease. Theoretical basis for anaerobic threshold determination. J Cardiopulm Rehabil 1995;15:193-196.
28. Jones NL, Rebuck AS. Rebreathing equilibration of C02 during exercise. JAppl Physiol 1973;35:538-541.
29. Reading JL, Goodman JM, Plyley MJ, et al. Vascular conductance and aerobic power in sedentary and active subjects and heart failure patients. J Appl Physiol 1993;74:567-573.
30. Kohrt WM, Spina RJ, Holloszy JO, Ehsani AA. Prescribing exercise intensity for older women. J Am Geriatr Soc 1998;46:129-133.
31. Diamond WJ. Practical Experiment Designs for Engineers and Scientists. Belmont, CA: Lifetime Learning Publications, 1981.
32. Redberg RF, Nishino M, McElhinney DB, Dae MW, Botvinick EH. Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease. Am Heart J 2000;139:739-744.
33. Lindheim SR, Notelovitz M, Feldman EB, Larsen S, Khan FY, Lobo RA. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women. Obstet Gynecol 1994;83:167-172.
34. Binder EF, Birge SJ, Kohrt WM. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women. J Am Geriatr Soc 1996;44:231-236.
35. Green JS, Crouse SF, Rohack JJ. Peak exercise hemodynamics in exercising postmenopausal women taking versus not taking supplemental estrogen. Med Sci Sports Exerc 1998;30:158-164.
36. McCole SD, Brown MD, Moore GE, Zmuda JM, Cwynar JD, Hagberg JM. Cardiovascular hemodynamics with increasing exercise intensities in postmenopausal women. J Appl Physiol 1999;87:2334-2340.
37. Aldrighi JM, Calvoso-Junior R, Alecrin IN, Trombetta IC, Negrao CE. Estrogen replacement and exercise capacity in postmenopausal women: a randomized placebo-controlled study. Gynecol Endocrinol 2005;21:324-329.
38. Snabes MC, Herd JA, Schuyler N, Dunn K, Spence DW, Young RL. In normal postmenopausal women physiologic estrogen replacement therapy fails to improve exercise tolerance: a randomized, double-blind, placebo-controlled, crossover trial. Am J Obstet Gynecol 1996;175:110-114.
39. Seals DR, Hagberg JM, Hurley BF, Ehsani AA, Holloszy JO. Endurance training in older men and women. I. Cardiovascular responses to exercise. J Appl Physiol 1984;57:1024-1029.
40. Spina RJ, Ogawa T, Kohrt WM, Martin WH 3rd, Holloszy JO, Ehsani AA. Differences in cardiovascular adaptations to endurance exercise training between older men and women. J Appl Physiol 1993;75:849-855.
41. Moreau KL, Donate AJ, Tanaka H, Jones PP, Gates PE, Seals DR. Basal leg blood flow in healthy women is related to age and hormone replacement therapy status. J Physiol 2003;547:309-316.
42. De Meersman RE, Zion AS, Giardina EG, Weir JP, Lieberman JS, Downey JA. Estrogen replacement, vascular distensibility, and blood pressures in postmenopausal women. Am J Physiol 1998;274:H1539-H1544.
43. Martin WH 3rd, Coyle EF, Bloomfield SA, Ehsani AA. Effects of physical deconditioning after intense endurance training on left ventricular dimensions and stroke volume. J Am Coll Cardiol 1986;7:982-989.
44. Mercuro G, Pitzalis L, Podda A, et al. Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women. Am J Cardiol 1999;84:214-218.
45. Martin WH 3rd, Kohrt WM, Malley MT, Korte E, Stoltz S. Exercise training enhances leg vasodilatory capacity of 65-yr-old men and women. J Appl Physiol 1990;69:1804-1809.
46. Martin WH 3rd, Ogawa T, Kohrt WM, et al. Effects of aging, gender, and physical training on peripheral vascular function. Circulation 1991;84:654-664.
47. Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: who is most bothered by vasomotor symptoms? Menopause 2008;15:841-847.